1.10
price down icon0.90%   -0.01
after-market Handel nachbörslich: 1.10
loading

Ensysce Biosciences Inc Aktie (ENSC) Neueste Nachrichten

pulisher
Dec 21, 2025

Will Ensysce Biosciences Inc. stock maintain growth storyWeekly Profit Recap & Free Community Supported Trade Ideas - Улправда

Dec 21, 2025
pulisher
Dec 21, 2025

Ensysce Biosciences’ Innovative Approach to Safer Opioid Use: A Clinical Study Update - MSN

Dec 21, 2025
pulisher
Dec 21, 2025

What sentiment indicators say about Ensysce Biosciences Inc. stockTrade Entry Summary & Fast Momentum Entry Tips - Улправда

Dec 21, 2025
pulisher
Dec 21, 2025

Why Ensysce Biosciences Inc. stock is considered a top pick2025 Trading Volume Trends & Weekly Stock Breakout Alerts - Улправда

Dec 21, 2025
pulisher
Dec 20, 2025

How buybacks impact Ensysce Biosciences Inc. stock valueEarnings Performance Report & Community Shared Stock Ideas - Улправда

Dec 20, 2025
pulisher
Dec 20, 2025

Can Ensysce Biosciences Inc. stock maintain operating margins2025 AllTime Highs & Verified Stock Trade Ideas - Улправда

Dec 20, 2025
pulisher
Dec 20, 2025

How Ensysce Biosciences Inc. stock reacts to Fed rate cutsWeekly Trade Report & Real-Time Volume Trigger Notifications - Улправда

Dec 20, 2025
pulisher
Dec 19, 2025

Resistance Check: Can Ensysce Biosciences Inc. stock maintain operating marginsMarket Performance Report & High Return Trade Guides - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Why Ensysce Biosciences Inc. stock is seen as undervaluedJuly 2025 Selloffs & Expert Approved Momentum Trade Ideas - Улправда

Dec 19, 2025
pulisher
Dec 15, 2025

Ensysce Biosciences Earnings Notes - Trefis

Dec 15, 2025
pulisher
Dec 13, 2025

EBIT per share of Ensysce Biosciences Inc. – OTC:ENSCW - TradingView — Track All Markets

Dec 13, 2025
pulisher
Dec 11, 2025

ENSC enrolls first patient in critical phase 3 trial - MSN

Dec 11, 2025
pulisher
Dec 11, 2025

Ensysce Biosciences initiates enrollment in Phase 3 trial of PF614 - MSN

Dec 11, 2025
pulisher
Dec 10, 2025

Ensysce Biosciences enrolls first patient in phase 3 pain drug trial - Investing.com Australia

Dec 10, 2025
pulisher
Dec 09, 2025

Should You Buy Ensysce Biosciences After Share Sale? - StocksToTrade

Dec 09, 2025
pulisher
Dec 09, 2025

Is Ensysce Biosciences a Hidden Gem? - timothysykes.com

Dec 09, 2025
pulisher
Dec 09, 2025

Ensysce Biosciences enrolls first patient in phase 3 pain drug trial By Investing.com - Investing.com South Africa

Dec 09, 2025
pulisher
Dec 09, 2025

Ensysce Biosciences Achieves Major Milestone with Initiation of Enrollment in Pivotal Phase 3 Trial of PF614, Its Next-Generation Opioid - Corsicana Daily Sun

Dec 09, 2025
pulisher
Dec 09, 2025

Ensysce Biosciences (NASDAQ: ENSC) starts Phase 3 PF614 trial in abuse-deterrent opioid - Stock Titan

Dec 09, 2025
pulisher
Dec 04, 2025

How Ensysce Biosciences Inc. stock performs in interest rate cyclesQuarterly Profit Review & Real-Time Buy Signal Notifications - Newser

Dec 04, 2025
pulisher
Dec 03, 2025

Why Ensysce Biosciences Inc. stock attracts high net worth investorsIPO Watch & Free Weekly Chart Analysis and Trade Guides - Newser

Dec 03, 2025
pulisher
Dec 02, 2025

Ensysce (NASDAQ: ENSC) secures MPAR overdose tech patent protection to 2042 - Stock Titan

Dec 02, 2025
pulisher
Dec 02, 2025

Is Ensysce Biosciences Inc. stock near bottom after declineEarnings Beat & Weekly High Conviction Trade Ideas - Newser

Dec 02, 2025
pulisher
Dec 02, 2025

Will Ensysce Biosciences Inc. stock outperform international peersProfit Target & Verified Stock Trade Ideas - Newser

Dec 02, 2025
pulisher
Dec 01, 2025

Ensysce Biosciences (ENSC) Stock Analysis Report | Financials & Insights - Benzinga

Dec 01, 2025
pulisher
Nov 28, 2025

Earnings Beat: Why Ensysce Biosciences Inc. stock is seen as undervalued2025 Volatility Report & Fast Gaining Stock Reports - moha.gov.vn

Nov 28, 2025
pulisher
Nov 28, 2025

Is Ensysce Biosciences, Inc. overvalued or undervalued? - Markets Mojo

Nov 28, 2025
pulisher
Nov 24, 2025

Ensysce Biosciences Inc. (ENSC) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 24, 2025
pulisher
Nov 21, 2025

Ensysce Biosciences, Inc.Common Stock (NQ: ENSC - Markets Financial Content

Nov 21, 2025
pulisher
Nov 21, 2025

[PRE 14A] Ensysce Biosciences, Inc. Preliminary Proxy Statement - Stock Titan

Nov 21, 2025
pulisher
Nov 21, 2025

Will Ensysce Biosciences Inc. stock benefit from AI adoption2025 Volatility Report & Community Shared Stock Ideas - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

Ensysce Biosciences Receives Positive FDA Feedback on PF614 Manufacturing Approach - The Joplin Globe

Nov 20, 2025
pulisher
Nov 20, 2025

Ensysce (NASDAQ: ENSC) Receives FDA Agreement on PF614 Commercial Manufacturing Approach - Stock Titan

Nov 20, 2025
pulisher
Nov 20, 2025

Why Ensysce Biosciences Inc. stock is popular among millennialsJuly 2025 Outlook & Growth Oriented Trade Recommendations - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

FY2025 Earnings Estimate for ENSC Issued By Zacks Small Cap - Defense World

Nov 20, 2025
pulisher
Nov 19, 2025

Real time social sentiment graph for Ensysce Biosciences Inc.New Guidance & Free Technical Pattern Based Buy Signals - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Ensysce Biosciences Inc. stock trading near support levelsTrade Exit Summary & Proven Capital Preservation Tips - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What the charts say about Ensysce Biosciences Inc. todayTrade Signal Summary & Weekly High Return Stock Forecasts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How currency fluctuations impact Ensysce Biosciences Inc. stockWeekly Investment Recap & Technical Analysis for Trade Confirmation - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Momentum divergence signals in Ensysce Biosciences Inc. chart2025 Technical Overview & Expert Verified Stock Movement Alerts - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

What catalysts could drive Ensysce Biosciences Inc. stock higherJuly 2025 Closing Moves & Weekly Top Gainers Alerts - newser.com

Nov 18, 2025
$39.22
price down icon 0.08%
$100.11
price down icon 0.33%
$33.42
price down icon 0.89%
$94.52
price down icon 0.54%
biotechnology ONC
$312.39
price up icon 0.21%
$177.88
price up icon 0.26%
Kapitalisierung:     |  Volumen (24h):